Cabot (NYSE:CBT) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Cabot (NYSE:CBT) from a hold rating to a buy rating in a research note published on Sunday.

CBT has been the subject of several other reports. UBS Group cut their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, August 5th. Truist Financial set a $100.00 price target on shares of Cabot in a research report on Wednesday, August 5th. Mizuho lifted their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. JPMorgan Chase & Co. upped their price objective on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Cabot presently has an average rating of “Hold” and a consensus price target of $89.00.

Cabot Trading Up 0.7%

Shares of NYSE:CBT opened at $87.03 on Friday. The stock has a market capitalization of $4.49 billion, a price-to-earnings ratio of 24.52, a PEG ratio of 11.28 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock’s 50-day simple moving average is $87.90 and its two-hundred day simple moving average is $80.16. Cabot has a 52-week low of $58.33 and a 52-week high of $94.53.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The business had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. During the same period in the previous year, the company posted $1.90 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Analysts expect that Cabot will post 6.33 EPS for the current year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. Cabot’s payout ratio is 53.24%.

Insider Transactions at Cabot

In other Cabot news, CEO Sean D. Keohane sold 91,923 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the sale, the chief executive officer owned 404,134 shares in the company, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 3.08% of the company’s stock.

Hedge Funds Weigh In On Cabot

A number of hedge funds have recently modified their holdings of the company. Torren Management LLC bought a new stake in shares of Cabot during the 4th quarter valued at $26,000. Rothschild Investment LLC boosted its holdings in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 259 shares during the period. Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares in the last quarter. Global Retirement Partners LLC increased its stake in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 466 shares in the last quarter. Finally, Danske Bank A S bought a new stake in Cabot during the third quarter valued at about $38,000. 93.18% of the stock is currently owned by institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.